Gilead Sciences Inc
(NAS:GILD)
$
92.15
1.15 (1.26%)
Market Cap: 114.84 Bil
Enterprise Value: 131.43 Bil
PE Ratio: 1,023.89
PB Ratio: 6.21
GF Score: 80/100 Gilead Sciences Inc at Cowen Health Care Conference (Virtual) Transcript
Mar 09, 2022 / 03:30PM GMT
Release Date Price:
$59
(-0.91%)
Tyler Martin Van Buren
Cowen and Company, LLC, Research Division - Analyst
Good morning, everyone. Welcome to the third day of Cowen's 42nd Annual Healthcare Conference. My name is Tyler Van Buren. I'm a senior biotech analyst here at Cowen. For this next session, we have a fireside chat with Gilead. It's my pleasure to introduce Andy Dickinson, Gilead's Chief Financial Officer. Andy, thank you very much for joining us here. It's a privilege to have you.
Andrew D. Dickinson
Gilead Sciences, Inc. - Executive VP & CFO
Thanks for having me. I'm happy to be here. Appreciate the invitation.
Tyler Martin Van Buren
Cowen and Company, LLC, Research Division - Analyst
Right. Before we get started, I want to mention to the audience that you can submit questions via the web portal or e-mail me at [email protected] and I'll do my best to get those answered.
Questions & Answers
Tyler Martin Van Buren
Cowen and Company, LLC, Research Division - Analyst
So we
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot